These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29530794)

  • 1. Nrf2 inhibits oxaliplatin-induced peripheral neuropathy via protection of mitochondrial function.
    Yang Y; Luo L; Cai X; Fang Y; Wang J; Chen G; Yang J; Zhou Q; Sun X; Cheng X; Yan H; Lu W; Hu C; Cao P
    Free Radic Biol Med; 2018 May; 120():13-24. PubMed ID: 29530794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formononetin ameliorates oxaliplatin-induced peripheral neuropathy via the KEAP1-NRF2-GSTP1 axis.
    Fang Y; Ye J; Zhao B; Sun J; Gu N; Chen X; Ren L; Chen J; Cai X; Zhang W; Yang Y; Cao P
    Redox Biol; 2020 Sep; 36():101677. PubMed ID: 32823168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
    Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
    Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Mechanism of Electroacupuncture on Peripheral Neurotoxicity Induced by Oxaliplatin in Rats.
    Wang FJ; Shi S; Wang YQ; Wang K; Fan SD; Zhang YN; Feng CC; Ju ZY
    Chin J Integr Med; 2022 Sep; 28(9):833-839. PubMed ID: 35799085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum accumulation in oxaliplatin-induced peripheral neuropathy.
    Wei G; Gu Z; Gu J; Yu J; Huang X; Qin F; Li L; Ding R; Huo J
    J Peripher Nerv Syst; 2021 Mar; 26(1):35-42. PubMed ID: 33462873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol prevents functional deficits in peripheral nerve mitochondria of rats with oxaliplatin-evoked painful peripheral neuropathy.
    Areti A; Komirishetty P; Kumar A
    Toxicol Appl Pharmacol; 2017 May; 322():97-103. PubMed ID: 28286117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies.
    Toyama S; Shimoyama N; Ishida Y; Koyasu T; Szeto HH; Shimoyama M
    Anesthesiology; 2014 Feb; 120(2):459-73. PubMed ID: 24064792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Effect of Salvianolic Acid A against Diabetic Peripheral Neuropathy through Modulation of Nrf2.
    Xu C; Hou B; He P; Ma P; Yang X; Yang X; Zhang L; Qiang G; Li W; Du G
    Oxid Med Cell Longev; 2020; 2020():6431459. PubMed ID: 32184918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitotherapy prevents peripheral neuropathy induced by oxaliplatin in mice.
    Maia JRLCB; Machado LKA; Fernandes GG; Vitorino LC; Antônio LS; Araújo SMB; Colodeti LC; Fontes-Dantas FL; Zeidler JD; Saraiva GN; Da Poian AT; Figueiredo CP; Passos GF; da Costa R
    Neuropharmacology; 2024 Mar; 245():109828. PubMed ID: 38158014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy.
    Areti A; Komirishetty P; Akuthota M; Malik RA; Kumar A
    J Pineal Res; 2017 Apr; 62(3):. PubMed ID: 28118492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.
    Griffith KA; Zhu S; Johantgen M; Kessler MD; Renn C; Beutler AS; Kanwar R; Ambulos N; Cavaletti G; Bruna J; Briani C; Argyriou AA; Kalofonos HP; Yerges-Armstrong LM; Dorsey SG
    J Pain Symptom Manage; 2017 Nov; 54(5):701-706.e1. PubMed ID: 28743660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Based on Systematic Pharmacology: Molecular Mechanism of Siwei Jianbu Decoction in Preventing Oxaliplatin-Induced Peripheral Neuropathy.
    Zhang P; Lu Y; Yang C; Zhang Q; Qian Y; Suo J; Cheng P; Zhu J
    Neural Plast; 2020; 2020():8880543. PubMed ID: 33082779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
    Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
    Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.
    Chen SJ; Chen LH; Yeh YM; Lin CK; Lin PC; Huang HW; Shen MR; Lin BW; Lee JC; Lee CC; Lee YF; Chiang HC; Chang JY
    Theranostics; 2021; 11(10):4672-4687. PubMed ID: 33754020
    [No Abstract]   [Full Text] [Related]  

  • 15. Paeoniflorin ameliorates oxaliplatin-induced peripheral neuropathy via inhibiting neuroinflammation through influence on gut microbiota.
    Xu J; Lu L; Jiang S; Qin Z; Huang J; Huang M; Jin J
    Eur J Pharmacol; 2024 May; 971():176516. PubMed ID: 38513881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi.
    Mizuno K; Shibata K; Komatsu R; Omiya Y; Kase Y; Koizumi S
    Cancer Biol Ther; 2016 Nov; 17(11):1206-1212. PubMed ID: 27416484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy.
    Gu H; Wang C; Li J; Yang Y; Sun W; Jiang C; Li Y; Ni M; Liu WT; Cheng Z; Hu L
    Int J Cancer; 2020 May; 146(10):2810-2821. PubMed ID: 31465111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homoeriodictyol protects human endothelial cells against oxidative insults through activation of Nrf2 and inhibition of mitochondrial dysfunction.
    Shen T; Li HZ; Li AL; Li YR; Wang XN; Ren DM
    Vascul Pharmacol; 2018 Oct; 109():72-82. PubMed ID: 29902531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidants Improve Oxaliplatin-Induced Peripheral Neuropathy in Tumor-Bearing Mice Model: Role of Spinal Cord Oxidative Stress and Inflammation.
    Agnes JP; Santos VWD; das Neves RN; Gonçalves RM; Delgobo M; Girardi CS; Lückemeyer DD; Ferreira MA; Macedo-Júnior SJ; Lopes SC; Spiller F; Gelain DP; Moreira JCF; Prediger RD; Ferreira J; Zanotto-Filho A
    J Pain; 2021 Aug; 22(8):996-1013. PubMed ID: 33774154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin-induced Peripheral Neuropathy.
    Tsukushi Y; Kobuchi S; Ito Y; Sakaeda T
    Anticancer Res; 2024 Feb; 44(2):575-584. PubMed ID: 38307592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.